Carboplatin Alone vs Carboplatin plus Epidoxorubicin as Second-Line Therapy for Cisplatin- or Carboplatin-Sensitive Ovarian Cancer-Reference-Cited by-同舟云学术

Carboplatin Alone vs Carboplatin plus Epidoxorubicin as Second-Line Therapy for Cisplatin- or Carboplatin-Sensitive Ovarian Cancer

Published:2001-04 Issue:1 Volume:81 Page:3-9
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Bolis Giorgio,Scarfone Giovanna,Giardina Giorgio,Villa Antonella,Mangili Giorgia,Melpignano Mauro,Presti Mauro,Tateo Saverio,Franchi Massimo,Parazzini Fabio

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference19 articles.

1. Cancer of the ovary;Cannistra;N Engl J Med,1993

2. Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer;Bolis;J Clin Oncol,1997

3. Treatment of refractory and recurrent ovarian cancer;Alberts;Semin Oncol,1999

4. Paclitaxel vs CAP (cyclophosphamide, Adriamycin, cisplatin) in recurrent cisplatin sensitive ovarian cancer: a randomized phase II study;Colombo;Proc Am Soc Clin Oncol,1996

5. Paclitaxel–anthracycline combination chemotherapy in relapsing advanced ovarian cancer after cisplatin-based chemotherapy: a pilot study;Kurtz;Gynecol Oncol,1998

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapeutic treatment options for recurrent epithelial ovarian cancer;Expert Opinion on Pharmacotherapy;2022-08-29

2. Malignant diseases of the ovary, fallopian tube, and peritoneum;Comprehensive Gynecology;2022

3. Combination of nigericin with cisplatin enhances the inhibitory effect of cisplatin on epithelial ovarian cancer metastasis by inhibiting slug expression via the Wnt/β‑catenin signalling pathway;Oncology Letters;2021-08-03

4. Secondary and tertiary ovarian cancer recurrence: what is the best management?;Gland Surgery;2020-08

5. Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review;Biochimica et Biophysica Acta (BBA) - General Subjects;2019-02